Drug Profile
Bee venom allergy vaccine - Allergopharma
Latest Information Update: 13 Aug 2015
Price :
$50
*
At a glance
- Originator Allergopharma
- Class Antiallergics; Hymenoptera allergy immunotherapies; Immunotherapies; Venoms
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Bee venom hypersensitivity
Most Recent Events
- 13 Aug 2015 No recent reports on development identified - Phase-III for Bee venom hypersensitivity (Prevention) in Germany (unspecified route)